These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 19736626)

  • 21. Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons.
    Rush AM; Craner MJ; Kageyama T; Dib-Hajj SD; Waxman SG; Ranscht B
    Eur J Neurosci; 2005 Jul; 22(1):39-49. PubMed ID: 16029194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of sodium channels in neuropathic pain.
    Rogers M; Tang L; Madge DJ; Stevens EB
    Semin Cell Dev Biol; 2006 Oct; 17(5):571-81. PubMed ID: 17123847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia.
    Siqueira SR; Alves B; Malpartida HM; Teixeira MJ; Siqueira JT
    Neuroscience; 2009 Dec; 164(2):573-7. PubMed ID: 19699781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium channel activity modulates multiple functions in microglia.
    Black JA; Liu S; Waxman SG
    Glia; 2009 Aug; 57(10):1072-81. PubMed ID: 19115387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models.
    Joshi SK; Honore P; Hernandez G; Schmidt R; Gomtsyan A; Scanio M; Kort M; Jarvis MF
    J Pain; 2009 Mar; 10(3):306-15. PubMed ID: 19070548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voltage-gated sodium channels and hyperalgesia.
    Lai J; Porreca F; Hunter JC; Gold MS
    Annu Rev Pharmacol Toxicol; 2004; 44():371-97. PubMed ID: 14744251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacology of voltage-gated sodium channels in sensory neurones.
    Docherty RJ; Farmer CE
    Handb Exp Pharmacol; 2009; (194):519-61. PubMed ID: 19655117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subtype-selective sodium channel blockers promise a new era of pain research.
    Priest BT; Kaczorowski GJ
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8205-6. PubMed ID: 17488822
    [No Abstract]   [Full Text] [Related]  

  • 29. Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain.
    Hoyt SB; London C; Gorin D; Wyvratt MJ; Fisher MH; Abbadie C; Felix JP; Garcia ML; Li X; Lyons KA; McGowan E; MacIntyre DE; Martin WJ; Priest BT; Ritter A; Smith MM; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4630-4. PubMed ID: 17588748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1.8 than in TTX-sensitive Na+ channels.
    Leffler A; Reiprich A; Mohapatra DP; Nau C
    J Pharmacol Exp Ther; 2007 Jan; 320(1):354-64. PubMed ID: 17005919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substituted biaryl pyrazoles as sodium channel blockers.
    Tyagarajan S; Chakravarty PK; Zhou B; Taylor B; Fisher MH; Wyvratt MJ; Lyons K; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Parsons WH
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5480-3. PubMed ID: 20709545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No gain, no pain: NaV1.7 as an analgesic target.
    King GF; Vetter I
    ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterned electrical activity modulates sodium channel expression in sensory neurons.
    Klein JP; Tendi EA; Dib-Hajj SD; Fields RD; Waxman SG
    J Neurosci Res; 2003 Oct; 74(2):192-8. PubMed ID: 14515348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Voltage-gated Na+ channels in neuropathic pain.
    Hargus NJ; Patel MK
    Expert Opin Investig Drugs; 2007 May; 16(5):635-46. PubMed ID: 17461737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
    Mulcahy JV; Pajouhesh H; Beckley JT; Delwig A; Du Bois J; Hunter JC
    J Med Chem; 2019 Oct; 62(19):8695-8710. PubMed ID: 31012583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.
    Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Thomas JB; Johnson MS; Carroll WA; Marron BE; Chapman ML; Liu D; Krambis MJ; Shieh CC; Zhang X; Hernandez G; Gauvin DM; Mikusa JP; Zhu CZ; Joshi S; Honore P; Marsh KC; Roeloffs R; Werness S; Krafte DS; Jarvis MF; Faltynek CR; Kort ME
    Bioorg Med Chem; 2008 Jun; 16(12):6379-86. PubMed ID: 18501613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
    Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
    Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity.
    Green BR; Bulaj G; Norton RS
    Future Med Chem; 2014 Oct; 6(15):1677-98. PubMed ID: 25406007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain.
    Frost JM; DeGoey DA; Shi L; Gum RJ; Fricano MM; Lundgaard GL; El-Kouhen OF; Hsieh GC; Neelands T; Matulenko MA; Daanen JF; Pai M; Ghoreishi-Haack N; Zhan C; Zhang XF; Kort ME
    J Med Chem; 2016 Apr; 59(7):3373-91. PubMed ID: 27015369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes.
    Bosmans F; Rash L; Zhu S; Diochot S; Lazdunski M; Escoubas P; Tytgat J
    Mol Pharmacol; 2006 Feb; 69(2):419-29. PubMed ID: 16267209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.